Hepatitis in marmosets

Area of Science:

• Virology
• Hepatology
• Primatology

Background:

• Human hepatitis A virus (HAV) infection is a significant public health concern.
• Marmosets serve as a valuable animal model for studying HAV pathogenesis and developing vaccines.
• Previous studies have established marmoset susceptibility to HAV via parenteral inoculation.

Purpose of the Study:

• To investigate marmoset susceptibility to human HAV through oral exposure.
• To characterize the presence and infectivity of HAV in marmoset feces.
• To compare the antigenic properties of different HAV strains and their implications for vaccine development.

Main Methods:

• Marmosets were inoculated with human HAV via parenteral and oral routes.
• Fecal samples were collected and analyzed for viral antigen and infectious virus particles.
• Antigenic characterization of HAV strains (MS-1, CR-326, GB) was performed using immune-adherence assays.
• Repeated challenge studies were conducted in immune marmosets.

Main Results:

• Marmosets demonstrated susceptibility to HAV through both parenteral and oral exposure.
• Infectious HAV particles and fecal antigen were detected in the stools of infected marmosets.
• The MS-1 and CR-326 HAV strains were antigenically similar, while the GB strain differed, potentially linking it to non-A/non-B hepatitis.
• Repeated HAV challenge in immune marmosets induced hyperergic responses with liver necrosis.

Conclusions:

• Oral exposure is a viable route for marmoset HAV infection.
• Marmoset feces can contain infectious HAV, suggesting fecal-oral transmission potential in this model.
• Distinct antigenic profiles of HAV strains necessitate strain-specific vaccine considerations.
• Hyperergic responses in immune animals require careful consideration for HAV vaccine efficacy and safety studies.